Centiva Capital’s Rallybio RLYB Stock Holding History

Centiva Capital’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,963	Closed	-$96.1K	–	2530
2024 Q2	$96.1K	Buy	+8,963	New	+$121K	﹤0.01%	1860

Other funds holding RLYB

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Centiva Capital's RLYB Position: Q3 2024 in Review

Centiva Capital sold out of Rallybio (RLYB) in Q3 2024, closing a stake of 8,963 shares — an estimated $96.1K sold.

Centiva Capital first reported a position in RLYB in Q2 2024 and held it in 1 quarter. The position peaked at $96.1K in Q2 2024. 49 funds tracked by Wall St. Rank hold RLYB as of Q3 2024.

Centiva Capital reported no remaining Rallybio position as of Q3 2024 after selling out during the quarter.
Centiva Capital sold 8,963 Rallybio shares in Q3 2024, an estimated $96.1K.
Centiva Capital first reported a position in Rallybio in Q2 2024 and held it in 1 quarter.
Centiva Capital's Rallybio position peaked at $96.1K in Q2 2024.
49 funds tracked by Wall St. Rank held Rallybio as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.